Vioxx Withdrawal Causes Concern About FDA
202073
Americans should feel reasonably safe taking government-approved prescription drugs &#151; with a few caveats &#151; even after a popular arthritis medication was pulled from the market, medical experts say. But the problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug, observers say.
140672
WASHINGTON - The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck & Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes, the chairman of the Senate Finance Committee said Thursday...
390243
People taking Vioxx may feel betrayed now that the popular painkiller and arthritis medicine has been pulled from the market. Merck, the manufacturer of the drug, and the US Food and Drug Administration knew
695199
Less than three months after Merck withdrew its pain-killer Vioxx from the US after concerns about side-effects, questions over Pfizer&#39;s competitor products are provoking
184964
Ever since Vioxx was pulled from the market over concerns about a risk of heart attack and stroke, arthritis patients have been asking doctors one question: What should I do now?
238647
The arthritis drug Vioxx, used by millions of people around the world, is being pulled off the market after a study confirmed long-standing concerns that it raises the risk of heart attack and stroke, the manufacturer, Merck & Co. , said on Thursday.
116806
WASHINGTON - Americans should feel reasonably safe taking government-approved prescription drugs - with a few caveats - even after a popular arthritis medication was pulled from the market, medical experts say. But the problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug, observers say...
420782
A US Food and Drug Administration reviewer who criticized the agency&#39;s handling of Merck &amp; Co. Inc.&#39;s now-withdrawn Vioxx painkiller may be forced to another position
90172
Merck Labs has pulled Vioxx, their arthritis drug, off the market after discovering during trials the possibility of a link to stroke or heart attack.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
230283
With Vioxx off the market because of links to heart problems and concerns growing about the related drugs Celebrex and Bextra, a pair of Food and Drug Administration advisory committees are assessing the safety of the popular painkillers.
26730
Prescription-drug recalls aren&#39;t common, and they&#39;re almost always controversial. Now that Merck (MRK ) is voluntarily withdrawing its Vioxx pain medication around the world, due to a heightened risk of cardiovascular
705819
WASHINGTON - Americans should feel reasonably safe taking government-approved prescription drugs - with a few caveats - even after a popular arthritis medication was pulled from the market, medical experts say.    Vioxx was the first prescription drug since 2001 to be taken off the market for safety reasons...
51395
Merck &amp; Co. withdrew the popular drug Vioxx from the market in September, after data from a clinical trial supported claims the medication was associated with an increased risk of heart attack and stroke.
80277
The arthritis drug Vioxx, used by  millions of people around the world, is being pulled off the  market after a study confirmed long-standing concerns that it  raises the risk of heart attack and stroke, the manufacturer,  Merck & Co. MRK.N, said on Thursday.
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent
463381
A U.S. Food and Drug Administration  reviewer who criticized the agency's handling of Merck & Co.  Inc.'s now-withdrawn Vioxx painkiller may be forced to another  position at the agency, a lawyer for the scientist said on  Monday.